Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Oral delivery of proteins and peptides has historically faced significant technical barriers due to the enzymatic degradation and poor permeability of macromolecules in the gastrointestinal (GI) tract ...

Semaglutide and other GLP-1 agonists for weight loss have had impressive ... also suggest that few patients follow the standard dosing schedule, with most staying on lower doses.

Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...

While GLP-1 agonists ... cessation of GLP-1 agonist monotherapy or GLP-1 agonist/inflammasome inhibitor combination therapy There is also potential to reduce the dose of GLP-1 agonists with ...

CAMBRIDGE, Mass., April 22, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today reported additional top ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs ... Some pens are single-use and contain a premeasured dose of the GLP-1 RA. In other cases, you select the amount of medication to be injected.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist ...